PF-Atlas › Clinical Trials › NCT00483769

One Year Glargine Treatment in CFRD Children and Adolescents

Glargine · Phase 4

Registry ID

NCT00483769

Phase

Phase 4

Status

Completed

Drug / intervention

Glargine

Sponsor

Federico II University

Start

2006-02

About this trial

Glargine is evaluated in NCT00483769, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Federico II University. Current status: Completed.

View NCT00483769 on ClinicalTrials.gov →

Explore related

All Glargine trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00483769 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.